Startup Dossier
Dillico
Deeptech biopharma startup developing All‑ScaleFlow™, an integrated, digitized, GMP-compliant platform for ultra-flexible, scalable manufacturing of mRNA vaccines and therapies. Aims to accelerate development, reduce costs, and enable personalized immuno-oncology treatments.
active
Typestartup
SectorBioTech
LocationMeylan
About
Deeptech biopharma startup developing All‑ScaleFlow™, an integrated, digitized, GMP-compliant platform for ultra-flexible, scalable manufacturing of mRNA vaccines and therapies. Aims to accelerate development, reduce costs, and enable personalized immuno-oncology treatments.
Structural DNA
Legal Name
Dillico
SIREN
913513412
Founders & Team
Funding Lineage
Series A
GP Compas (Lead)
€7.5M
Jul 2025
Programs
i-Lab
2023Pharmacie & biotechnologies